Back to search

Article

Synthetic gene circuits that selectively target RAS-driven cancers

2024-11-11

Abstract excerpt

Therapies targeting mutated RAS, the most frequently mutated oncogene in human cancers, could benefit millions of patients. Recently approved RAS inhibitors represent a breakthrough, but are limited to a specific KRAS G12C mutation and prone to resistance. Synthetic gene circuits offer a promising alternative by sensing and integrating cancer-specific biomolecular inputs, including mutated RAS, to selectively exp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3e577ae8-18b2-5d8a-a003-ec7cc573fdad
DOI
10.1101/2024.11.11.622942
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Synthetic gene circuits that selectively target RAS-driven cancersDOI 10.1101/2024.11.11.622942
Select a neighboring publication to make it the new centre.